BPC-157 10mg · Research brief
Bulk BPC-157: Pricing, Testing and MOQs for Labs
Short answer
Two vials labelled '10mg BPC-157 ' can hold measurably different quantities of peptide. Not because anyone shorted the fill weight, but because purity and net peptide content are two entirely different measurements, and most bulk BPC-157 listings publish only the first one.
Key takeaways
- HPLC purity and net peptide content are different measurements: a 99% pure peptide can still contain less peptide by mass than the stated fill weight, because counterion salt and residual water count toward gross weight.
- BPC-157 is a synthetic pentadecapeptide, sequence GEPPPGKPADDAGLV, molecular weight around 1419 Da, supplied as lyophilised powder for laboratory research use only.
- A certificate of analysis is only useful if its batch number matches the number printed on the vial you actually received.
- Mass spectrometry (ESI-MS or MALDI-TOF) confirms identity, while HPLC alone confirms only that a single species dominates the chromatogram.
- MOQs on bulk BPC-157 exist because per-batch QC and vialling are fixed costs that amortise across quantity, not because suppliers prefer larger invoices.
- Domestically held stock dispatched within 24 hours removes customs delay and the unrecorded temperature excursions of long international shipping.
Two vials labelled '10mg BPC-157' can hold measurably different quantities of peptide. Not because anyone shorted the fill weight, but because purity and net peptide content are two entirely different measurements, and most bulk BPC-157 listings publish only the first one.
We run small-batch synthesis and per-batch QC at Real Peptides, and we've read enough third-party certificates of analysis to know exactly where the gaps sit. Buyers pricing bulk BPC-157 almost always open with cost per milligram. The questions that decide whether a shipment is actually usable in a lab come later, and those are the ones this page answers.
What is bulk BPC-157 and what do research buyers receive?
Bulk BPC-157 is body protection compound-157, a synthetic 15-amino-acid peptide (sequence GEPPPGKPADDAGLV, molecular weight around 1419 Da), supplied as lyophilised powder in sealed glass vials for laboratory research use only. Volume orders are priced in per-vial tiers, ship with a batch-specific certificate of analysis, and are not approved by the FDA as drug products.
The oversimplification worth killing early is that wholesale BPC-157 is a commodity where price per milligram is the only variable. It isn't. Two quotes at identical prices can differ on net peptide content, counterion salt, residual solvent, batch traceability, and whether the certificate on file was generated for the vials in your box or for a batch made long before it. This page covers what bulk BPC-157 arrives as physically, how to verify a supplier's testing, and what genuinely moves wholesale pricing.
What a volume order actually arrives as
Bulk BPC-157 ships as a lyophilised (freeze-dried) white to off-white cake or powder, sealed in glass vials under a butyl rubber stopper and an aluminium crimp seal. Research-scale vials are commonly filled at 5mg or 10mg of gross weight. Larger quantities are usually supplied as unvialled powder in a single sealed container, which lowers the per-milligram cost, because vialling, stoppering, capping and labelling are labour steps rather than chemistry.
The compound itself is a pentadecapeptide: fifteen amino acids, sequence GEPPPGKPADDAGLV, molecular weight around 1419 Da. It is described in the literature as a partial sequence derived from a protein found in gastric juice, which is where the name body protection compound comes from. Published work on it is overwhelmingly preclinical, in animal and in vitro models, and research suggests interest has centred on tissue repair pathways rather than on any approved clinical use.
Handling matters more than most listings admit. Lyophilised peptide tolerates ambient temperature across a short transit window, which is why powder ships without dry ice, but tolerant is not the same as indefinite. Long-term research stock is held desiccated at -20°C or below and protected from light. Reconstituted solution is a different material with a far shorter usable life and needs refrigeration at 2-8°C.
In our experience, the most common intake complaint from labs that ordered a bulk BPC-157 lot elsewhere isn't purity at all. It's a vial label with no batch number printed on it, which makes the certificate of analysis unmatchable and the material useless for any work that has to be documented.
The testing questions that separate documentation from decoration
Purity on a certificate of analysis is a relative number, not an absolute one, and that distinction decides whether your order is what the label says. Reverse-phase HPLC (high-performance liquid chromatography) measures the target peak as a percentage of total UV-absorbing material detected at 214nm or 220nm. A 99% result means 99% of what the detector saw was your peptide. It says nothing about how much of the vial's mass is peptide in the first place.
That second number is net peptide content, and it's where bulk BPC-157 purchasing quietly goes wrong. Gross fill weight includes the counterion left over from purification, typically trifluoroacetate (TFA), plus residual water absorbed by a hygroscopic freeze-dried cake. Net content is established by amino acid analysis or nitrogen determination, and it is never 100% of gross weight. A vial reporting 99% HPLC purity can therefore hold measurably less peptide than the figure printed on the label, with both statements true at the same time.
Identity is the third leg. A bulk BPC-157 certificate that reports purity without mass spectrometry has confirmed that one species dominates the chromatogram, not which species it is. ESI-MS or MALDI-TOF matching observed mass against the theoretical value is what ties that peak to BPC-157 specifically.
Then check traceability. The batch number on the certificate must match the number on the vial, the analysis date should sit close to the synthesis date, and the testing laboratory should be named. Certificates published openly and searchable by batch, as ours are, take the trust question off the table entirely.
What actually moves wholesale pricing, and how ordering works
Price per milligram on bulk BPC-157 falls with volume for reasons rooted in chemistry and labour rather than negotiation. Solid-phase peptide synthesis costs scale with chain length and sequence difficulty, and BPC-157 carries a run of three consecutive prolines, a well-known coupling challenge that suppresses crude yield. A tighter purity specification cuts yield again, because a narrower purification cut discards more material at the shoulders of the peak. Per-batch QC is a fixed cost: the same HPLC run, mass spec and any amino acid analysis or endotoxin panel cost the same whether the batch is small or large.
MOQs on bulk BPC-157 exist because of that fixed-cost structure. Below a certain quantity, testing, vialling and documentation dominate the invoice and the per-milligram price stops falling.
Logistics are the other half of the number. Stock held domestically dispatches within 24 hours and skips customs clearance entirely, which removes both the multi-week lead time and the unrecorded temperature excursions that come with long international transit. Wholesale BPC-157 ordered from an overseas manufacturer often looks cheaper on the quote and costs more once independent re-testing on arrival is priced in.
One boundary isn't negotiable: bulk BPC-157 is supplied strictly for laboratory research use, is not an FDA-approved drug product, and is not for human or veterinary consumption. Nothing here is dosing, administration or protocol guidance. Any question involving an animal subject belongs with a licensed veterinarian, and any question involving a person belongs with a licensed physician.
How bulk BPC-157 supply routes compare
Buyers comparing bulk BPC-157 suppliers usually choose between four sourcing routes, and the real difference between them is documentation and lead time rather than the molecule. This table sets out what each route typically delivers and where the risk actually sits.
| Sourcing route | Documentation typically supplied | Lead time and handling risk | Bottom line for research buyers |
|---|---|---|---|
| Overseas manufacturer, direct | Often a batch-agnostic or undated certificate, sometimes with no testing laboratory named | Weeks in transit plus customs clearance, with temperature history unrecorded | Lowest headline price per gram, highest verification burden. Only workable if you can fund independent HPLC and mass spec on arrival. |
| General marketplace or reseller listing | Reused certificate images, batch numbers that rarely match vial labels | Unclear chain of custody, repackaging frequently done outside a controlled environment | The cheapest possible way to buy an unidentified white powder. Unsuitable for any documented research. |
| Domestic supplier holding stock | Batch-specific certificate with HPLC purity and mass spectrometry identity, published and searchable by batch | Dispatch within 24 hours from held inventory, no customs step, short transit at ambient | Best fit for labs that need traceable material on a predictable schedule and can't absorb re-testing delays. |
| Contract or custom synthesis | Full batch record, custom purity specification, optional amino acid analysis and endotoxin panel | Lead time measured in weeks, MOQ set by synthesis scale rather than stock | The right call for modified analogues or non-standard specifications. Overkill and slow for catalogue material. |
What If: Sourcing And Handling Scenarios
What if the shipment arrives warm?
Document the condition, photograph the packaging as received, and ask the supplier for the batch stability data before doing anything else. Lyophilised peptide is comparatively robust across a short ambient excursion, which is why a bulk BPC-157 order ships without dry ice, but robust is not the same as unaffected. Freeze-dried material that arrives visibly liquefied, oily or discoloured has taken on moisture and should be treated as compromised. There is no valid at-home test for degradation: appearance is a screening cue, not an assay, and only re-analysis by HPLC settles the question.
What if the supplier only offers a representative certificate?
Ask for the batch-specific document, and treat a refusal as the answer. A representative certificate proves a supplier once produced material at a stated purity. It proves nothing about the vials sitting in your box. Batch-specific testing is the entire function of a certificate of analysis, and if the batch number on the paperwork can't be matched to the number on the vial label, the purity claim is unverifiable for the purposes of documented research.
What if the lyophilised cake looks cracked, shrunken or stuck to the vial wall?
Record it and flag it to the supplier, but don't assume failure. Cake morphology varies with fill volume, freezing rate and shelf temperature during lyophilisation, and a cracked or partially collapsed cake is a cosmetic outcome far more often than a chemical one. What does warrant escalation is a cake that has slumped into a glassy film, or any visible moisture inside the vial, both of which point to a seal or humidity problem. Purity is confirmed by the certificate, never by the cake.
What if my order sits below the supplier's minimum?
Ask whether the minimum applies per compound or per invoice total, because it is frequently the latter. A bulk BPC-157 minimum built around fixed per-batch QC costs can often be met by combining several catalogue compounds into a single order rather than over-buying one peptide you'll then store for two years. Storage time carries its own cost: material held at -20°C across multiple years accumulates handling and stability risk, and ordering well beyond what a project needs is a false economy.
The uncomfortable part about gram-level quotes
Here's the honest answer: when one quote for bulk BPC-157 sits far below everyone else's, the gap is almost never manufacturing efficiency. It's testing that didn't happen, a purity specification set loose enough to keep yield high, or net peptide content nobody measured because measuring it would lower the number on the label. Peptide synthesis costs what it costs. A gram you then have to send to an independent laboratory for HPLC and mass spec confirmation, at your expense and on your timeline, was never actually the cheaper gram.
If you're comparing suppliers, the fastest test is documentation you can inspect before you spend anything: our published certificates of analysis are searchable by batch, the research peptide catalogue lists purity specifications and vial formats per compound, and the stock and shipping page sets out where inventory is held and how quickly it dispatches.
Bulk BPC-157 procurement rewards the buyer who reads the certificate before the price list. Purity percentages are easy to print and hard to fake only when someone is checking, and it's net peptide content, batch traceability and confirmed identity that turn a sealed vial of white powder into a defined research material. The suppliers worth keeping are the ones whose paperwork you can verify without having to ask them for it. That's the whole test, and it takes about ten minutes.
References
Peer-reviewed sources on BPC-157 indexed in PubMed, listed for research context. Real Peptides supplies BPC-157 for laboratory research use only.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2025. PMID 40756949. doi:10.1177/15563316251355551
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals (Basel, Switzerland), 2025. PMID 40005999. doi:10.3390/ph18020185
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current reviews in musculoskeletal medicine, 2025. PMID 40789979. doi:10.1007/s12178-025-09990-7
- Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review. Pharmaceuticals (Basel, Switzerland), 2024. PMID 39204186. doi:10.3390/ph17081081
- From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. International journal of molecular sciences, 2026. PMID 41898733. doi:10.3390/ijms27062876
- BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. International journal of molecular sciences, 2026. PMID 42278509. doi:10.3390/ijms27114984
- Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury. Scientific reports, 2026. PMID 42204242. doi:10.1038/s41598-026-55449-1
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Joint diseases and related surgery, 2026. PMID 42542926. doi:10.52312/jdrs.2026.2951
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA